Literature DB >> 15084370

Impact of diabetes mellitus on long-term survival in patients with congestive heart failure.

Pascal De Groote1, Nicolas Lamblin, Frédéric Mouquet, David Plichon, Eugène McFadden, Eric Van Belle, Christophe Bauters.   

Abstract

AIMS: To test the hypothesis that diabetic status may be used as a prognostic indicator in heart failure (HF) patients. METHODS AND
RESULTS: We studied 1246 consecutive patients with left ventricular dysfunction. All patients had a cardiopulmonary exercise test and an echocardiogram. Cardiac catheterisation was systematically performed to define HF aetiology. Twenty-two percent of the patients were diabetic (hypoglycaemic drugs or fasting blood glucose >126 mg/dL); in diabetic patients, HF aetiology was ischaemic in 58% vs. 40% in non-diabetic patients ( p < 0.0001). Clinical follow-up (median 1200 days) was obtained for 1241 patients. There was a statistically significant effect of diabetes mellitus on cardiac survival that differed according to HF aetiology (interaction p > 0.01). Diabetes mellitus was an independent predictor of cardiovascular mortality in ischaemic patients (HR=1.54 [1.13; 2.09]; P = 0.006) but not in non-ischaemic patients (HR=0.65 [0.39; 1.07];p = 0.09). When diabetic patients were defined as patients receiving hypoglycaemic drugs at baseline, diabetes mellitus remained an independent predictor of cardiovascular mortality in ischaemic patients (HR=1.43 [1.03; 1.98]; p = 0.03) while diabetes mellitus was associated with a statistically significant decrease in cardiovascular mortality in non-ischaemic patients (HR=0.46 [0.23; 0.88]; p = 0.02).
CONCLUSION: The prognostic impact of diabetes mellitus in HF patients is markedly influenced by the underlying aetiology and is particularly deleterious in those with ischaemic cardiomyopathy.

Entities:  

Mesh:

Year:  2004        PMID: 15084370     DOI: 10.1016/j.ehj.2004.01.010

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  42 in total

Review 1.  Diabetic heart disease.

Authors:  T H Marwick
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

2.  Predictors of mortality and hospitalization in women with heart failure in the Digitalis Investigation Group trial.

Authors:  Ali Ahmed; Wilbert S Aronow; Jerome L Fleg
Journal:  Am J Ther       Date:  2006 Jul-Aug       Impact factor: 2.688

Review 3.  Use of metformin in diseases of aging.

Authors:  John M Miles; Andrew D Rule; Barry A Borlaug
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

Review 4.  Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.

Authors:  Robert J Mentz; Jacob P Kelly; Thomas G von Lueder; Adriaan A Voors; Carolyn S P Lam; Martin R Cowie; Keld Kjeldsen; Ewa A Jankowska; Dan Atar; Javed Butler; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2014-11-24       Impact factor: 24.094

Review 5.  Noncardiac comorbidities and acute heart failure patients.

Authors:  Robert J Mentz; G Michael Felker
Journal:  Heart Fail Clin       Date:  2013-05-23       Impact factor: 3.179

6.  Association of heart failure severity with risk of diabetes: a Danish nationwide cohort study.

Authors:  Malene N Demant; Gunnar H Gislason; Lars Køber; Allan Vaag; Christian Torp-Pedersen; Charlotte Andersson
Journal:  Diabetologia       Date:  2014-05-22       Impact factor: 10.122

Review 7.  Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review.

Authors:  Dean T Eurich; Finlay A McAlister; David F Blackburn; Sumit R Majumdar; Ross T Tsuyuki; Janice Varney; Jeffrey A Johnson
Journal:  BMJ       Date:  2007-08-30

8.  A pilot test of an integrated self-care intervention for persons with heart failure and concomitant diabetes.

Authors:  Sandra B Dunbar; Brittany Butts; Carolyn M Reilly; Rebecca A Gary; Melinda K Higgins; Erin P Ferranti; Steven D Culler; Javed Butler
Journal:  Nurs Outlook       Date:  2013-10-02       Impact factor: 3.250

9.  [ESC/EASD joint guidelines on diabetes and cardiovascular diseases].

Authors:  Wolfgang Motz; Rolf Dörr
Journal:  Herz       Date:  2009-02       Impact factor: 1.443

10.  Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study.

Authors:  Selma F Mohammed; Barry A Borlaug; Véronique L Roger; Sultan A Mirzoyev; Richard J Rodeheffer; Julio A Chirinos; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2012-10-17       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.